2024 was a banner year for biotech, with significant investments in AI-powered drug discovery and protein engineering and fewer down and flat rounds. Though M&A activity is muted, the IPO market is promising. A handful of companies have already filed for IPOs in 2025 and decent performances from companies that debuted in 2024 should build confidence.
Read the full article: SVB: Healthcare Industry Trends – 2024 Annual Report //
Source: https://www.svb.com/trends-insights/reports/healthcare-investments-and-exits/